Mind Medicine Australia Free Webinar: Eating Disorders & Psychedelic-Assisted Psychotherapy: Synergies & Urgently Needed Investigations with Dr. Marissa Raymond-Flesch

Don’t miss out - Get your tickets early!

Join this FREE WEBINAR presented by Dr Marissa Raymond-Flesch (USA).

TOPIC: Eating Disorders & Psychedelic-Assisted Psychotherapy: Synergies & Urgently Needed Investigations

This talk will introduce the possible applications of psychedelic-assisted therapy for adolescents and young adults with eating disorders. It will include (1) a brief review of the epidemiology of eating disorders in adolescents and young adults, including the need for novel treatments; (2) describe the neurobiological underpinnings of anorexia nervosa and how psilocybin therapy may work synergistically to influence those factors which perpetuate anorexia nervosa and (3) illustrate key elements of a clinical trial of psilocybin therapy, including opportunities for stakeholder engagement.

Objectives:

• Explain the hypothesized mechanisms of action through which psilocybin-assisted therapy might improve symptoms of anorexia nervosa.

• Summarize available research on psilocybin for patients with anorexia nervosa.

• Identify developmental considerations for psychedelic therapy in adolescent and young adult populations.

EVENT DETAILS

• DATE: 16th September 2026

• TIME: 11:55am AEST for 12:00pm start, finishing at 1:15pm

• DURATION: 75 minutes

• LOCATION: Online - a link will be emailed to you with the viewing details

ABOUT THE PRESENTER

Dr Marissa Raymond-Flesch
MD, MPH, Director, K Prep Program
University of California, San Francisco

Dr. Raymond-Flesch is a Professor in the Philip R. Lee Institute for Health Policy Studies (IHPS) and the Division of Adolescent and Young Adult Medicine within the Department of Pediatrics. Clinically, she practices Adolescent Medicine with patients 12 to 26 years old, including treatment of depression, anxiety, and eating disorders; providing all types of contraception; and providing primary care for patients with complex medical and mental health conditions. Her program of research focuses on understanding and improving the mental health, reproductive health, and healthcare access of adolescents and young adults, particularly those from rural and underserved communities. She is especially interested in using community-based participatory research to design meaningful research projects and create health inventions that communities want and need.

---

MEDICINAL PSYCHEDELIC TREATMENTS

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT

Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.

DISCLAIMER

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.